BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 30948337)

  • 21. Open versus endovascular REBOA control of blood loss during cesarean delivery in the placenta accreta spectrum: A single-center retrospective case control study.
    Riazanova OV; Reva VA; Fox KA; Romanova LA; Kulemin ES; Riazanov AD; Ioscovich A
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():23-28. PubMed ID: 33388487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrum.
    Overton E; Booker WA; Mourad M; Moroz L; Nhan Chang CL; Breslin N; Syeda S; Laifer-Narin S; Cimic A; Chung DE; Weiner DM; Smiley R; Sheikh M; Mobley DG; Wright JD; Gockley A; Melamed A; St Clair C; Hou J; D'Alton M; Khoury Collado F
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100657. PubMed ID: 35597402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage.
    Mehrabadi A; Hutcheon JA; Liu S; Bartholomew S; Kramer MS; Liston RM; Joseph KS;
    Obstet Gynecol; 2015 Apr; 125(4):814-821. PubMed ID: 25751202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women.
    Kasraeian M; Hashemi A; Hessami K; Alamdarloo SM; Vahdani R; Vafaei H; Najib FS; Shiravani Z; Razavi B; Homayoon N; Nayebi M; Bazrafshan K; Jahromi MA
    BMC Womens Health; 2021 Jun; 21(1):243. PubMed ID: 34130685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine conservation in placenta accrete spectrum (PAS) disorders: A retrospective case series: Is expectant management beneficial in reducing maternal morbidity?
    Lional KM; Tagore S; Wright AM
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():212-217. PubMed ID: 33011503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study.
    Fitzpatrick KE; Sellers S; Spark P; Kurinczuk JJ; Brocklehurst P; Knight M
    BJOG; 2014 Jan; 121(1):62-70; discussion 70-1. PubMed ID: 23924326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study.
    Schwickert A; van Beekhuizen HJ; Bertholdt C; Fox KA; Kayem G; Morel O; Rijken MJ; Stefanovic V; Strindfors G; Weichert A; Weizsaecker K; Braun T;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():29-40. PubMed ID: 33524163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].
    Daney de Marcillac F; Lecointre L; Guillaume A; Sananes N; Fritz G; Viville B; Boudier E; Nisand I; Gaudineau A; Langer B; Akladios CY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):849-858. PubMed ID: 27118678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta.
    Bodner LJ; Nosher JL; Gribbin C; Siegel RL; Beale S; Scorza W
    Cardiovasc Intervent Radiol; 2006; 29(3):354-61. PubMed ID: 16502171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Placement of Internal Iliac Balloons in Patients with Abnormal Placental Implantation: Maternal and Foetal Outcomes.
    Nicholson PJ; O'Connor O; Buckley J; Spence LD; Greene RA; Tuite DJ
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1488-1493. PubMed ID: 29777276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placenta accreta spectrum: accreta, increta, and percreta.
    Silver RM; Barbour KD
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):381-402. PubMed ID: 26002174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative infrarenal abdominal aorta balloon catheter occlusion combined with Bakri tamponade reduced maternal morbidity of placenta increta/percreta.
    Zeng C; Yang M; Ding Y; Yu L; Deng W; Hu Y; Gong X
    Medicine (Baltimore); 2017 Sep; 96(38):e8114. PubMed ID: 28930860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prophylactic placement of internal iliac artery balloon catheters on outcomes of women with placenta accreta: an impact study.
    Feng S; Liao Z; Huang H
    Anaesthesia; 2017 Jul; 72(7):853-858. PubMed ID: 28401537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure.
    Piñas Carrillo A; Chandraharan E
    Womens Health (Lond); 2019; 15():1745506519878081. PubMed ID: 31578123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Prophylactic Balloon-Assisted Occlusion of the Internal Iliac Arteries in the Management of Placenta Increta/Percreta.
    Cho SB; Hong SJ; Lee S; Won JH; Choi HC; Ha JY; Moon JI; Park JK; Park JE; Park SE
    Medicina (Kaunas); 2020 Jul; 56(8):. PubMed ID: 32717928
    [No Abstract]   [Full Text] [Related]  

  • 38. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique.
    Palacios-Jaraquemada JM; Fiorillo A; Hamer J; Martínez M; Bruno C
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):275-282. PubMed ID: 31984808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective study of placenta accreta, placenta increta and placenta percreta in Peripartum hysterectomy specimens.
    Heena AB; Kumari G
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S87-S90. PubMed ID: 32108636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.